Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients

BACKGROUND: The osteocyte-derived hormone, fibroblast growth factor 23 (FGF23), regulates the phosphorus metabolism and suppresses 1,25-dihydroxyvitamin D production, thereby mitigating hyperphosphatemia in patients with renal disorders. An elevated FGF23 level is suggested to be an early biomarker...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cardiorenal Med
Päätekijät: Chathoth, Shahanas, Al-Mueilo, Samir, Cyrus, Cyril, Vatte, Chittibabu, Al-Nafaie, Awatif, Al-Ali, Rudaynah, Keating, Brendan J., Al-Muhanna, Fahad, Al Ali, Amein
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2015
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698654/
https://ncbi.nlm.nih.gov/pubmed/27194998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000440984
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia